Please login to the form below

Not currently logged in

Project Orbis

This page shows the latest Project Orbis news and features for those working in and with pharma, biotech and healthcare.

Bayer’s Nubeqa receives MHRA approval to treat metastatic prostate cancer

Bayer’s Nubeqa receives MHRA approval to treat metastatic prostate cancer

Nubeqa, which is already available on the NHS for patients with localised prostate cancer, was reviewed and approved through Project Orbis, an international programme to speed up the approval process of

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...